Amgen AMGN reported fourth-quarter 2024 adjusted earnings of $5.31 per share, which beat the Zacks Consensus Estimate of $5.03 per share. Earnings rose 13% year over year as higher revenues were ...

Shares of Rhythm PharmaceuticalsRYTM wavered Tuesday after the biotech's experimental weight-loss drug missed its mark in a yearlong study. The company hoped to show targeting gene variants along the ...

Eli Lilly and Company LLY reported second-quarter 2025 adjusted earnings per share (“EPS”) of $6.31, which beat the Zacks Consensus Estimate of $5.61 per share. Earnings rose 61% year over year.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...